Thoracic injection of low-dose interleukin-2 as an adjuvant therapy improves the control of the malignant pleural effusions: a systematic review and meta-analysis base on Chinese patients

Is still there a role for IL-2 for solid tumors other than melanoma or renal cancer?

(2017) Giandomenico Roviello et al.   Immunotherapy

Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion

(2017) Hirozo Sakaguchi et al.   LUNG CANCER

Management of malignant pleural effusion: challenges and solutions

(2017) Erika Penz et al.   Cancer Management and Research

Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study

(2017) Alison Pearce et al.   PLoS One

Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis

(2016) Rong Biaoxue et al.   BMC CANCER

Interleukin-2 reverses CD8+T cell exhaustion in clinical malignant pleural effusion of lung cancer

(2016) C. Y. Hu et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Role of IL-2 in cancer immunotherapy

(2016) Tao Jiang et al.   OncoImmunology

Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion

(2016) Rong Biaoxue et al.   Scientific Reports

Thoracic perfusion of matrine as an adjuvant treatment improves the control of the malignant pleural effusions

(2015) Rong Biaoxue et al.   World Journal of Surgical Oncology

Fever and the use of paracetamol during IL-2-based immunotherapy in metastatic melanoma

(2014) Anne Helene Køstner et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014

(2014) Janice P Dutcher et al.   Journal for ImmunoTherapy of Cancer

Vaccine therapy for metastatic melanoma

(2011) Ming Chi et al.   MELANOMA RESEARCH